National Cancer Institute (NCI): Lung Neoplasms trials

The registry lists 224 Lung Neoplasms studies with National Cancer Institute (NCI) as lead sponsor. 18 are open to participants now and 84 have results posted.

Early Phase 1 1Phase 1 72Phase 2 118Phase 3 21No phase 32(a study in two phases counts in both)

Studies

Page 3 of 3. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00019929Phase 2
• Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the PleuraCompletedNCT00019825Phase 1
• LMB-9 Immunotoxin in Treating Patients With Advanced Solid TumorsCompletedNCT00019435Phase 1
• Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsCompletedNCT00019331Phase 2
• Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung CancerCompletedNCT00019201Not applicable
• Vaccine Therapy and Biological Therapy in Treating Patients With Advanced CancerCompletedNCT00019084Phase 2
• Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung CancerCompletedNCT00019006Phase 1
• Fenretinide in Treating Patients With Recurrent Small Cell Lung CancerCompletedNCT00009971Phase 2
• Immunotoxin Therapy in Treating Patients With Advanced CancerCompletedNCT00006981Phase 1
• Suramin, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung CancerCompletedNCT00006929Phase 2
• Lung Screening StudyCompletedNCT00006382Not applicable
• SU5416 in Treating Patients With Malignant MesotheliomaCompletedNCT00006014Phase 2
• Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By SurgeryCompletedNCT00005838Phase 3
• Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced CancerTerminatedNCT00005655Phase 1
• Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung CancerCompletedNCT00005065Phase 1
• Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2CompletedNCT00004883Phase 2
• Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
• Standard Therapy Given With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung CancerStatus unknownNCT00003240Phase 3
• Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung CancerCompletedNCT00002852Phase 3
• Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaCompletedNCT00002625Phase 1
• Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung CancerCompletedNCT00002537Phase 1
• A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by RituximabCompletedNCT00001805Phase 2
• Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung CancerCompletedNCT00001499Phase 2
• Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLCCompletedNCT00001450Phase 2